Financhill
Back

Apellis Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Apellis Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 21.6 Buy
20-day SMA: 20.47 Buy
50-day SMA: 22.93 Buy
200-day SMA: 21.99 Buy
8-day EMA: 21.71 Buy
20-day EMA: 21.42 Buy
50-day EMA: 22.33 Buy
200-day EMA: 24.23 Sell

Apellis Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 2449128 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.42 - 21.5) Buy
Bollinger Bands (100): (20.46 - 26.84) Sell

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Apellis Pharmaceuticals, Inc. Stock

Is Apellis Pharmaceuticals, Inc. Stock a Buy?

APLS Technical Analysis vs Fundamental Analysis

Buy
53
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy or a Sell?

Apellis Pharmaceuticals, Inc. Stock Info

Market Cap:
3B
Price in USD:
23.63
Share Volume:
4.3M

Apellis Pharmaceuticals, Inc. 52-Week Range

52-Week High:
35.72
52-Week Low:
16.10
Buy
53
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Apellis Pharmaceuticals, Inc. Share Price Forecast

Is Apellis Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Apellis Pharmaceuticals, Inc.

Is Apellis Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Technical Analysis of Apellis Pharmaceuticals, Inc.

Should I short Apellis Pharmaceuticals, Inc. stock?

* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.